Trials / Unknown
UnknownNCT03402191
L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension
Comparative Clinical Study Evaluating the Effect of L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Sherief Abd-Elsalam · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This study compares L-arginine Versus Sildenafil as treatment for pulmonary hypertension in Children with Beta Thalassemia
Detailed description
This study focuses on different lines of treatment for pulmonary hypertension in children with thalassemia as this study discusses the Effect of L-arginine Versus Sildenafil in Children with Beta Thalassemia Associated with Pulmonary Hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | L-arginine | l-arginine for thalassemia with pulmonary hypertension |
| DRUG | Sildenafil | Sildenafil for thalassemia with pulmonary hypertension |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2018-01-18
- Last updated
- 2018-08-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03402191. Inclusion in this directory is not an endorsement.